Correlation Between Leap Therapeutics and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Leap Therapeutics and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Leap Therapeutics and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Leap Therapeutics and Seres Therapeutics, you can compare the effects of market volatilities on Leap Therapeutics and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Leap Therapeutics with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Leap Therapeutics and Seres Therapeutics.
Diversification Opportunities for Leap Therapeutics and Seres Therapeutics
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Leap and Seres is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Leap Therapeutics and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Leap Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Leap Therapeutics are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Leap Therapeutics i.e., Leap Therapeutics and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Leap Therapeutics and Seres Therapeutics
Given the investment horizon of 90 days Leap Therapeutics is expected to under-perform the Seres Therapeutics. In addition to that, Leap Therapeutics is 1.02 times more volatile than Seres Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Seres Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest 539.00 in Seres Therapeutics on November 2, 2024 and sell it today you would lose (453.17) from holding Seres Therapeutics or give up 84.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Leap Therapeutics vs. Seres Therapeutics
Performance |
| Timeline |
| Leap Therapeutics |
| Seres Therapeutics |
Leap Therapeutics and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Leap Therapeutics and Seres Therapeutics
The main advantage of trading using opposite Leap Therapeutics and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Leap Therapeutics position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Leap Therapeutics vs. X4 Pharmaceuticals | Leap Therapeutics vs. Terns Pharmaceuticals | Leap Therapeutics vs. Day One Biopharmaceuticals | Leap Therapeutics vs. PDS Biotechnology Corp |
| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |